Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,243 | -47,305 | -35,731 | -24,084 | -12,006 |
| Depreciation Amortization | 86 | 477 | 375 | 259 | 133 |
| Accounts payable and accrued liabilities | 619 | -73 | -133 | 280 | 61 |
| Other Working Capital | 1,650 | -2,491 | -2,470 | -2,889 | -681 |
| Other Operating Activity | 1,773 | 10,065 | 7,900 | 5,097 | 2,810 |
| Operating Cash Flow | $-11,115 | $-39,327 | $-30,059 | $-21,337 | $-9,683 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -62 | -218 | -178 | -118 | -106 |
| Purchase Of Investment | -12,714 | -24,372 | -20,383 | -18,351 | -8,532 |
| Sale Of Investment | 24,278 | 58,474 | 47,474 | 33,751 | 27,351 |
| Investing Cash Flow | $11,502 | $33,884 | $26,913 | $15,282 | $18,713 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 210 | 2,191 | 1,643 | 1,550 | 331 |
| Financing Cash Flow | $210 | $2,191 | $1,643 | $1,550 | $331 |
| Beginning Cash Position | 12,823 | 16,075 | 16,075 | 16,075 | 16,075 |
| End Cash Position | 13,420 | 12,823 | 14,572 | 11,570 | 25,436 |
| Net Cash Flow | $597 | $-3,252 | $-1,503 | $-4,505 | $9,361 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,115 | -39,327 | -30,059 | -21,337 | -9,683 |
| Capital Expenditure | -62 | -218 | -178 | -118 | -106 |
| Free Cash Flow | -11,177 | -39,545 | -30,237 | -21,455 | -9,789 |